Kahn Swick & Foti, LLC is investigating Humana Inc. following the company's 2023 financial results, which revealed a higher benefits expense ratio and a significant drop in adjusted earnings per share (EPS) compared to prior forecasts. Humana reported a 2023 adjusted EPS of $26.09, over $2 less than predicted, and expects 2024 EPS to fall further to $16, well below analyst expectations. This led to a securities class action lawsuit alleging failure to disclose material information. The court has allowed the case to proceed, and the investigation is examining potential breaches of fiduciary duty by Humana's officers and directors. Investors with relevant information or concerns are invited to contact KSF for legal guidance.
